| UniProt/SwissProt ID: | FUBP1_HUMAN |
| Description: | far upstream element (FUSE) binding protein 1 [Source:HGNC Symbol;Acc:4004] |
| Location: | chr1 p31.1 |
| Node attribute: | substrate; TF |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| S99 | QQQSRsVMTEE | | HPRD |
| S52 | GDAGTsLNSND | | PhosphoSitePlus; HPRD |
| S84 | APQNDsFGTQL | | PhosphoSitePlus; HPRD |
| Y619 | AWAEYyRQQAA | DUF1897 | PhosphoSitePlus |
| S55 | GTSLNsNDYGY | | HPRD |
| Y60 | SNDYGyGGQKR | | PhosphoSitePlus |
| Y268 | EVRNEyGSRIG | | PhosphoSitePlus |
| Y4 | __MADySTVPP | | PhosphoSitePlus |
| S630 | YYAQTsPQGMP | | PhosphoSitePlus; HPRD; phosphoELM; SysPTM |
| T229 | DGPQNtGADKP | KH_1 | PhosphoSitePlus |
| S140 | QIAPDsGGLPE | | HPRD; phosphoELM |
| S270 | RNEYGsRIGGN | | PhosphoSitePlus |
| Y618 | AAWAEyYRQQA | DUF1897 | PhosphoSitePlus |
| T229 | DGPQNtGADKP | | HPRD |
| T207 | GKGGEtIKQLQ | KH_1 | PhosphoSitePlus |
| Y58 | LNSNDyGYGGQ | | PhosphoSitePlus; HPRD; phosphoELM |
| Y589 | KAWEEyYKKMG | | PhosphoSitePlus |
| S140 | QIAPDsGGLPE | KH_1 | PhosphoSitePlus |
| T153 | CMLTGtPESVQ | KH_1 | PhosphoSitePlus; SysPTM |
| T153 | CMLTGtPESVQ | | HPRD; phosphoELM; SysPTM |
| T207 | GKGGEtIKQLQ | | HPRD |
| S156 | TGTPEsVQSAK | KH_1 | PhosphoSitePlus |
| Y626 | QQAAYyAQTSP | | PhosphoSitePlus; HPRD |
| Y242 | ITGDPyKVQQA | KH_1 | PhosphoSitePlus |
| T398 | GKGGEtIKSIS | KH_1 | PhosphoSitePlus |
| Y4 | TVPP | | HPRD |
| T629 | AYYAQtSPQGM | | PhosphoSitePlus; HPRD; SysPTM |
| Y625 | RQQAAyYAQTS | | PhosphoSitePlus; HPRD |
|
FUBP1_HUMAN do not have dephosphorylation site.
|
|
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|
| ENSP00000359804 | P281L | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000359804 | H463fs*>182 | COSMIC | Central Nervous System Neoplasms | 21817013 |
| ENSP00000359804 | Q548* | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000359804 | E445* | COSMIC | Central Nervous System Neoplasms | 21817013 |
| ENSP00000359804 | E411* | COSMIC | Central Nervous System Neoplasms | 21817013 |
| ENSP00000359804 | D570fs*>75 | COSMIC | Central Nervous System Neoplasms | 21817013 |
| ENSP00000359804 | A596T | COSMIC | Central Nervous System Neoplasms | 18772396 |
|
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|
| ENSP00000359804 | Gastric Cancer | Metastasis | cell line | Down | 0.69 | 17022644 |
| ENSP00000359804 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 2.9 | 15759316 |
| ENSP00000359804 | Leukemia | Normal vs. Cancer | cell line | Down | 0.47 | 17022645 |
| ENSP00000359804 | Leukemia | Normal vs. Cancer | cell line | Down | 0.47 | 17022645 |
| ENSP00000359804 | Lung Cancer | Treatment (none vs. FK228 treatment) | cell line | Down | | 18549279 |
| ENSP00000359804 | Breast Cancer | Treatment (none vs. 17b-Estradiol treatment) | cell line | Up | 2.4 | 18491314 |
| ENSP00000359804 | hepatitis B virus | Normal vs. Cancer | tissue | Up | 3.6 | 19003864 |
| ENSP00000359804 | Lung Cancer | Treatment(none vs 20 mg/mL GTE treatment) | cell line | Up | 5.5 | 19137550 |
| ENSP00000359804 | Lung Cancer | Treatment(none vs 40 mg/mL GTE treatment) | cell line | Up | 6.3 | 19137550 |
| ENSP00000359804 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Down | 0.2 | 20804217 |
| ENSP00000359804 | Gastric Cancer | Metastasis | cell line | Down | 0.69 | 17022644 |
| ENSP00000359804 | chronic myeloid leukemia | Treatment (Imatinib-sensitive vs. Imatinib-resistant) | cell line | Down | | 20417730 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.06 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.09 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.12 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.07 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.09 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 0.18 | 17655343 |
| ENSP00000359804 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | | 17655343 |
| ENSP00000359804 | Ovarian Cancer | Metastasis | cell line | Up | | 17892554 |
| ENSP00000359804 | Biliary Tract Cancer | Metastasis | cell line | Up | 3.1 | 19299076 |
| ENSP00000359804 | Pancreatic Cancer | Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) | cell line | Down | 0.4 | 20944110 |
|
| FUBP1_HUMAN do not have hyperphosphorylation site. |
|
FUBP1_HUMAN is not in KEGG pathway.
|
|
| GO ID | GO_Term | Evidence | Ontology |
|---|
| GO:0003697 | single-stranded DNA binding | TAS | molecular_function |
| GO:0003723 | RNA binding | IEA | molecular_function |
| GO:0003700 | sequence-specific DNA binding transcription factor | TAS | molecular_function |
| GO:0006366 | transcription from RNA polymerase II promoter | TAS | biological_process |
| GO:0005634 | nucleus | IDA | cellular_component |
| GO:0010628 | positive regulation of gene expression | IDA | biological_process |
| GO:0005515 | protein binding | IEA | molecular_function |
|
Fatal error: Uncaught Error: Call to undefined function mysql_close() in /usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php:23
Stack trace:
#0 /usr/local/apache/htdocs/PhoSigNet/proteintable.php(435): db_disconnect(Object(mysqli))
#1 {main}
thrown in
/usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php on line
23